INTERNATIONAL JOURNAL OF DERMATOLOGY, cilt.47, sa.6, ss.622-625, 2008 (SCI-Expanded)
Background High-dose isotretinoin has been reported to have adverse effects on bone mineral density (BMD); however, studies evaluating changes in BMD with isotretinoin therapy at different dosages and with varying treatment durations have produced conflicting results.